TABLE 1.
Strains and plasmids used in this study
| Species and strain | Relevant marker(s) or genotype(s) | Reference or source |
|---|---|---|
| E. coli | ||
| S17-1 | λpir | Lorenzo and Timmis (100) |
| P. aeruginosa PA14 | ||
| CNP17 | Wild type (WT) | Hogan lab |
| CNP26 | WT with mKO-κ | This study |
| CNP12 | ΔpelA | Friedman and Kolter (30) |
| CNP27 | ΔpelA with mKO-κ | This study |
| CNP18 | ΔwspR | Chen et al. (21) |
| CNP28 | ΔwspR with mKO-κ | This study |
| CNP70 | ΔbapA | Hogan lab |
| CNP77 | ΔbapA with mKO-κ | This study |
| CNP65 | ΔpilY1 | Hogan lab |
| CNP67 | ΔpilY1 with mKO-κ | This study |
| CNP21 | Δanr | Hogan lab |
| CNP50 | Δanr with mKO-κ | This study |
| CNP69 | ΔpchEpvdA | Hogan lab |
| CNP76 | ΔpchEpvdA with mKO-κ | This study |
| CNP22 | ΔlasR | Hogan lab |
| CNP56 | ΔlasR with mKO-κ | This study |
| CNP41 | Δphz | Hogan lab |
| CNP54 | Δphz with mKO-κ | This study |
| CNP43 | 63LB4 clinical CF isolate | Hogan lab |
| CNP44 | 63LG4 clinical CF isolate | Hogan lab |
| CNP45 | 63RA7 clinical CF isolate | Hogan lab |
| CNP46 | 63RE10 clinical CF isolate | Hogan lab |
| CNP59 | 63LB4 clinical CF isolate with mKO-κ | This study |
| CNP57 | 63LG4 clinical CF isolate with mKO-κ | This study |
| CNP60 | 63RA7 clinical CF isolate with mKO-κ | This study |
| CNP58 | 63RE10 clinical CF isolate with mKO-κ | This study |
| C. albicans CAI4 | ||
| CNC1 | WT with pACT-GFP | Hogan lab |
| CNC11 | WT with pACT mKATE2 | This study |